دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 12,000,000 تومان- قیمت ویژه : 6,250,000تومان
دسترسی ۳ ماهه به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 93 ﺭﻭﺯ
قیمت : 4,000,000 تومان- قیمت ویژه : 1,750,000تومان
When Diagnostic Criteria Redefine Disease: Lessons From the Padua and European Task Force Criteria.
doi : 10.1161/CIRCULATIONAHA.125.076411
Volume 152(22) pgs. 1523-1589,e420-e426 December 02, 2025
Peri-Interventional Anesthesia Strategies for Transcatheter Aortic Valve Implantation: A Multicenter, Randomized, Controlled, Noninferiority Trial.
Transcatheter Aortic Valve Replacement With Local Anesthesia: When Less Is Less?.
The Role of the Collateral Circulation in Stable Angina: An Invasive Placebo-Controlled Study.
Characterizing the Immune Response in Pig-to-Human Heart Xenografts Using a Multimodal Diagnostic System.
IRF5 siRNA Nanoimmunotherapy: Restoring Macrophage Efferocytosis in Atherosclerosis.
The Diagnostic Challenge of Irregular Tachycardia Accompanied by Alternating Bundle Branch Block.
Chordin-Like 1 mRNA Therapy for Acute Myocardial Infarction.
Letter by Wu et al Regarding Article, "Bleeding and New Malignancy Diagnoses After Anticoagulation for Atrial Fibrillation: A Population-Based Cohort Study".
Response by Abdel-Qadir et al to Letter Regarding Article, "Bleeding and New Malignancy Diagnoses After Anticoagulation for Atrial Fibrillation: A Population-Based Cohort Study".
Letter by Hu et al Regarding Article, "Efficacy and Safety of Non-Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of 4 Randomized Clinical Trials of Patients With Atrial Fibrillation".
Response by Patel and Giugliano to Letter Regarding Article, "Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of 4 Randomized Clinical Trials of Patients With Atrial Fibrillation".
